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Performing a genome-wide association study (GWAS) of S. Typhi invasion, Alvarez 
et al. (1) identify a trait-associated single nucleotide polymorphism (SNP), rs8060947, 
in VAC14. rs8060947 is an expression quantitative trait locus (eQTL) for VAC14 
RNA expression, and carriage of the A allele is associated with reduced VAC14 RNA 
and protein expression, and increased invasion of S. Typhi. VAC14-associated 
inhibition of S. Typhi invasion is mediated by a reduction in host cell membrane 
cholesterol. Carriage of the A allele at rs8060947 is associated with typhoid fever in 
Vietnamese individuals (cases = 496, controls = 500; P = 0.01, additive odds ratio 
[OR] = 1.38). The authors further identify a SNP in high linkage disequilibrium with 
rs8060947, rs8044133, located in a transcription factor binding site, which merits 
further investigation as the causative SNP. 
 
Alvarez et al. note that cholesterol has been implicated in the invasion and 
pathogenesis of a wide range of pathogens (2-5). We therefore used GWAS data from 
Kenyan children with bacteraemia (6) secondary to diverse pathogens (n = 1,536) and 
healthy control children from the same population (n = 2,677), to explore whether 
genetic variation at the VAC14 locus is associated with susceptibility to invasive 
bacterial infections other than typhoid fever (SI Methods). In Kenyan children, 
rs8060947 is significantly associated with all-cause bacteremia: Padditive = 0.02, OR = 
1.11 (95% confidence interval [CI] 1.02-1.22). In keeping with the effect observed in 
typhoid, carriage of the A allele at rs8060947 increases risk of bacteremia. 
 
To understand whether risk of bacteremia conferred by rs8060947 is shared across 
pathogens causing bacteremia in Kenyan children, we conducted a Bayesian analysis 
(SI Methods) comparing models of association at rs8060947 with the major causes of 
bacteremia in this population (Fig. 1A). The most probable model is one in which 
rs8060947 is associated with susceptibility to bacteraemia caused by nontyphoidal 
Salmonella (NTS), S. pneumoniae, E. coli and Acinetobacter species, but not 
bacteremia caused by other pathogens (Fig. 1B). We performed imputation-based 
mapping of the association at the VAC14 locus with bacteraemia secondary to NTS, S. 
pneumoniae, E. coli and Acinetobacter species (Fig. 1C). In that analysis, there is 
evidence for association between bacteremia secondary to these four pathogens and 
both rs8060947 (Padditive = 4.76x10
-3, OR = 1.17 [95% CI = 1.05-1.30]) and rs8044133 
(Padditive = 4.58x10
-3, OR = 1.17 [95% CI = 1.05-1.30]). 
 
Alvarez et al. demonstrate that genetic variation in VAC14 is a determinant of clinical 
typhoid fever in Vietnamese individuals. Our data expand on this observation, 
demonstrating that the same risk allele at rs8060947, with a comparable effect size, 
increases risk of bacteraemia secondary to diverse pathogens in Kenyan children. This 
observation may reflect a previously unrecognised role for cholesterol in the 
pathogenesis of diverse bacterial pathogens, or a role for cholesterol in a shared risk 
factor for these pathogens in this population, e.g. malaria or HIV. Future studies will 
be required to further define the range of clinical diseases associated with VAC14, and 
to fine-map the genetic signal at VAC14. 
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Fig. 1. Association between the VAC14 locus and major causes of bacteremia in 
Kenyan children. (A) rs8060947 association with the major causes of bacteremia in 
Kenyan children; nontyphoidal Salmonella, n = 180, S. aureus, n = 175,  S. 
pneumoniae, n = 426, E. coli, n = 151, β-hemolytic Streptococci, n = 146, H. 
influenza type b, n = 128, Acinetobacter species, n = 130. Log-transformed odds 
ratios and 95% confidence intervals of rs8060947 association (additive model) with 
each pathogen. (B) Posterior probabilities of models of association at rs8060947: 
NULL, no association with any bacterial pathogen; SAME, the same effect across all 
bacterial pathogens; REL, related effects across all bacterial pathogens; BEST, a non-
zero effect in bacteremia secondary to nontyphoidal Salmonella, S. aureus, S. 
pneumoniae and Acinetobacter species alone; this model (highlighted in red) is the 
most probable (Bayes factor c.f. NULL = 14). (C) Association plot of bacteremia 
susceptibility at the VAC14 locus. SNPs are colored according to strength of linkage 
disequilibrium (r2) to rs8060947. Association statistics are calculated using an 
additive model including bacteraemia cases secondary to nontyphoidal Salmonella, S. 
aureus, S. pneumoniae and Acinetobacter species (n = 887) and shared, healthy 
controls (n = 2,677). 
  
Supporting Information 
SI Methods 
Genetic association analysis of bacteraemia in Kenyan children at VAC14 
The GWAS of all-cause bacteraemia in Kenyan children has been described in detail 
elsewhere (1). In brief, Kenyan children under the age of 13 years, presenting to Kilifi 
District Hospital, Kenya, between 1st August 1998 and 30th October 2010, with 
community-acquired bacteraemia were recruited to the GWAS. Healthy community 
controls were recruited as a birth cohort from the same population between 1st May 
2006 and 30th April 2008. Following DNA extraction and quality control (1), genome-
wide genotyping was performed using an Affymetrix SNP 6.0 chip. Genome-wide 
imputation was performed with SHAPEIT (2) and IMPUTE2 (3) using 1000G Phase 
1 as a reference panel. Association analysis was performed under an additive model 
of association, in SNPTEST2 (4), including the first four principal components of 
genome-wide genotyping data to correct for population structure. 
In this analysis of the VAC14 locus, we included common (minor allele frequency 
>0.05), well-imputed SNPs (imputation info score >0.4), with no evidence for 
departure from Hardy Weinberg equilibrium (P>1x10-10). rs8060947 was directly 
genotyped on the Affymetrix SNP 6.0 chip (Fig. S1). In this population, rs8060947 
has a minor allele frequency of 0.44, with no evidence of departure from Hardy 
Weinberg equilibrium (P = 0.11). rs8044133 is imputed (imputation info score = 
0.996), and has a minor allele frequency of 0.47, with no evidence of departure from 
Hardy Weinberg equilibrium (P = 0.73). Following quality control, 1,536 cases and 
2,677 control samples were included in the analysis. 
 Bayesian comparison of models of association 
 
We compared models of association at candidate loci across the seven most 
frequently isolated bacterial pathogens (NTS, n = 180; S. pneumoniae, n = 426; S. 
aureus, n = 175; H. influenza type b, n = 128; β-haemolytic Streptococci, n = 146; E. 
coli, n = 151; Acinetobacter, n = 130) among cases of bacteraemia in the Kenyan 
discovery samples in the all-cause bacteraemia GWAS (1). Effect size estimates and 
95% confidence intervals were calculated by multinomial logistic regression under a 
recessive model, using control status and each of the bacterial pathogen subgroups as 
strata, and the first two principal components as covariates. We considered three 
models of effect across the bacterial pathogens, defined by the prior distributions on 
the effect size: 
 
NULL: effect size = 0, i.e. no association with any pathogen. 
SAME: effect size ~ N(0,0.2) and fixed between pathogens (ρ=1). 
REL: effect size ~ N(0,0.2) and correlated (ρ=0.96), but not fixed, between 
pathogens. 
 
These three models were considered alongside a fourth model defined as a 
combination of pathogens with the same non-zero effect (with no effect for other 
pathogens), for which the data provides support. For each model we calculated 
approximate Bayes factors (5) and posterior probabilities, assuming each model to be 
equally likely a priori.  
  
SI Figures 
 
SI Fig. 1. Cluster plot of rs8060947 in Kenyan children (n = 4,924). 
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